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abstract
 
We have produced transgenic mice which overexpress cardiac Na
 
1
 
-Ca
 
2
 
1
 
 
 
exchange activity. Overex-
pression has been assessed by Western blot, Northern blot, and immunofluorescence. Functional overexpression
was analyzed using membrane vesicles and isolated ventricular myocytes. In whole cell clamped myocytes dialyzed
with 0.1–0.2 mM Fura-2, the magnitude of I
 
Ca 
 
and Ca
 
2
 
1
 
i
 
-transient triggered by I
 
Ca 
 
or caffeine were not significantly
different in transgenic vs. control myocytes. In transgenic myocytes, activation of I
 
Ca
 
, however, was followed by a
large slowly inactivating transient inward current representing I
 
Na-Ca
 
. This current depended on Ca
 
2
 
1
 
 
 
release as it
was abolished when sarcoplasmic reticulum (SR) Ca
 
2
 
1
 
 
 
was depleted using thapsigargin. Ca
 
i
 
-transients triggered by
rapid application of 5 mM caffeine, even though equivalent in control and transgenic myocytes, activated larger
 
I
 
Na-Ca 
 
(
 
z
 
5 pA/pF at 
 
2
 
90 mV) in transgenic vs.
 
 
 
control myocytes (1.5 pA/pF). The decay rate of caffeine-induced
Ca
 
2
 
1
 
i
 
-transient and I
 
Na-Ca 
 
was 2.5 times faster in transgenic than in control myocytes. 5 mM Ni
 
2
 
1
 
 
 
was equally effec-
tive in blocking I
 
Na-Ca 
 
in control or transgenic myocytes. In 9 out of 26 transgenic myocytes, but none of the con-
trols, Ca
 
2
 
1
 
 
 
influx via the exchanger measured at 
 
1
 
80 mV caused a slow rise in [Ca
 
2
 
1
 
]
 
i 
 
triggering rapid release of
Ca
 
2
 
1
 
 
 
from the SR. SR Ca
 
2
 
1
 
 
 
release triggered by the exchanger at such potentials was accompanied by activation of
transient current in the inward direction. In 2 mM Fura-2–dialyzed transgenic myocytes caffeine-triggered Ca
 
i
 
-
transients failed to activate I
 
Na-Ca
 
, even though the kinetics of inactivation of I
 
Ca 
 
slowed significantly in caffeine-
treated myocytes. In 0.1 mM Fura-2–dialyzed transgenic myocytes 100 
 
m
 
M Cd
 
2
 
1
 
 effectively blocked I
 
Ca 
 
and sup-
pressed Ca
 
i
 
-transients at 
 
2
 
10 or 
 
1
 
50 mV. Our data suggests that in myocytes overexpressing the exchanger, the
content of intracellular Ca
 
2
 
1
 
 
 
pools and the signaling of its release by the Ca
 
2
 
1
 
 channel vis-à-vis the Na
 
1
 
-Ca
 
2
 
1
 
 
 
ex-
changer were not significantly altered despite an up to ninefold increase in the exchanger activity. We conclude
that the exchanger remains functionally excluded from the Ca
 
2
 
1
 
 
 
microdomains surrounding the DHP/ryanodine
receptor complex.
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introduction
 
Regulation of Ca
 
2
 
1
 
 fluxes in cardiac myocytes is a com-
plex process involving multiple transporters, channels,
and compartments. A key transport process is that me-
diated by the Na
 
1
 
-Ca
 
2
 
1
 
 exchange protein. The Na
 
1
 
-Ca
 
2
 
1
 
exchanger catalyzes the countertransport of three Na
 
1
 
ions for one Ca
 
2
 
1
 
 
 
ion across the sarcolemmal mem-
brane and is the major Ca
 
2
 
1
 
 
 
efflux mechanism of myo-
cardial cells. Ca
 
2
 
1
 
 
 
extrusion by the exchanger helps bring
about muscle relaxation after contraction. Thus, while
the Ca
 
2
 
1
 
 channels of sarcolemma (DHP receptors) pro-
vide the primary route for entry of Ca
 
2
 
1
 
, the Na
 
1
 
-Ca
 
2
 
1
 
exchanger serves as a primary route for Ca
 
2
 
1
 
 extrusion.
To maintain and regulate cytosolic Ca
 
2
 
1
 
 concentrations
during the contraction/relaxation cycle, the activity of
the two pathways ultimately must be balanced. Al-
though the role of the Na
 
1
 
-Ca
 
2
 
1
 
 exchanger in the ef-
flux of Ca
 
2
 
1
 
 has been quantified and is universally ac-
cepted, the physiological role of the exchanger in the
Ca
 
2
 
1
 
 influx mode has been somewhat controversial and
not generally agreed upon (Callewaert, 1992; Levesque
et al., 1994; Lipp and Niggli, 1994; Sham et al., 1992).
This controversy may be related, in part, to different
levels of expression of the exchanger in different spe-
cies (Sham et al., 1995
 
b
 
). Ca
 
2
 
1
 
 cross signaling experi-
ments between the DHP and ryanodine receptors in
myocytes dialyzed with high concentrations of Ca
 
2
 
1
 
buffers, however, suggest that the exchanger protein
might be excluded from the “functional” microdomain
of Ca
 
2
 
1
 
 
 
surrounding the DHP/ryanodine receptor com-
plex (Sham et al., 1995
 
a
 
; Adachi-Akahane et al., 1996),
even though immunofluorescence techniques have sug-
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Na
 
1
 
-Ca
 
2
 
1
 
 Exchange Overexpression
 
gested that the exchanger is located in the t-tubular sys-
tem near diadic or triadic junctures (Frank et al., 1992;
Kieval et al., 1992).
The availability of the cDNA clone for the Na
 
1
 
-Ca
 
2
 
1
 
exchanger (Nicoll et al., 1990) allows new approaches
to physiological problems regarding the exchanger.
For example, antisense oligonucleotides have been used
to “knock out” exchange activity in both cardiac and ar-
terial myocytes (Lipp et al., 1995; Sidzinski et al., 1995).
Transgenic mouse technology offers another opportu-
nity to manipulate Na
 
1
 
-Ca
 
2
 
1
 
 
 
exchange activity. Here we
describe the production and characterization of trans-
genic mice overexpressing Na
 
1
 
-Ca
 
2
 
1
 
 
 
exchange activity
specifically in cardiac muscle. Myocytes from the trans-
genic mice have increased I
 
Na-Ca 
 
and were used to fur-
ther probe the ability of I
 
Na-Ca 
 
and the Ca
 
2
 
1
 
 
 
channel to
trigger Ca
 
2
 
1
 
 
 
release. Even with the increased density of
I
 
Na-Ca
 
, the exchanger failed to trigger Ca
 
2
 
1
 
 
 
release from
the sarcoplasmic reticulum (SR)
 
1
 
 in the physiological
voltage range.
 
materials and methods
 
Production of Transgenic Mice
 
The transgene construct (Fig. 1) consisted of the open reading
frame of the canine cardiac Na
 
1
 
-Ca
 
2
 
1
 
 exchanger (Nicoll et al.,
1990) under the control of the 
 
a
 
-myosin heavy chain (
 
a
 
-MHC)
promoter. The 
 
a
 
-MHC promoter consisted of 4.5 kb of 5
 
9
 
 up-
stream sequence plus 1 kb of the 
 
a
 
-MHC gene encompassing ex-
ons 1 through 3 of the 5
 
9
 
 untranslated region (Gulick et al., 1991;
Subramaniam et al., 1991). The presence of upstream introns
and exons may improve expression of a transgene (Palmiter et
al., 1991). Downstream from the 
 
a
 
-MHC promoter was the SV40
transcriptional terminator to provide a polyadenylation signal.
The exchanger open reading frame was removed from pTB11
(Nicoll et al., 1990) by digestion with EcoRV and SnaBl and li-
gated into the SalI site between the 
 
a
 
-MHC promoter and the
SV40 transcriptional terminator. The SalI site had first been di-
gested, blunted, and dephosphorylated. Proper orientation of
the exchanger insert was confirmed by restriction mapping. The
transgene was purified by GeneClean (Bio 101, La Jolla, CA) and
microinjected into the nuclei of C57Bl/6xC3HF1 mice by the
UCLA Transgenic Core Facility for transgenic mouse production.
Eight lines (A through H) of transgenic mice were generated.
Southern blot analysis was used to confirm the presence of the
transgene in the mouse genome. Genomic DNA was extracted
from tail clippings, digested with EcoRI, and size fractionated on
a 0.8% agarose gel. After transfer to nitrocellulose, the DNA was
probed with the 0.4-kb EcoRI fragment from pTB11. This por-
tion of the open reading frame of the Na
 
1
 
-Ca
 
2
 
1
 
 exchanger is de-
rived from a region of the NCX1 gene encompassing several ex-
ons (Kofuji et al., 1994). Thus, on the Southern blot, the 0.4-kb
probe would hybridize with the 0.4-kb fragment derived from the
EcoRI-digested transgene which contains no exchanger introns.
Digestion of the endogenous mouse exchanger gene, however,
with EcoRI did not produce a similar sized fragment. Prehybrid-
ization and hybridization were carried out as described previ-
ously (Li et al., 1994).
 
Northern Blot Analysis
Total RNA was isolated from mouse tissues by the method of
Chomczynski and Sacchi (1987). The RNA was separated on a
denaturing 1% agarose gel and transferred onto a Hybond-N ny-
lon filter. The same 0.4-kb cDNA fragment used in the Southern
blot analysis above was also used for Northern blot analysis. Hy-
bridization conditions were also the same.
Western Blot Analysis
Proteins were first separated on a 7.5% gel by SDS-PAGE and
transferred onto nitrocellulose for 30 min at 100 V. Washings
and antibody incubations were carried out in the presence of 1%
milk. The primary polyclonal antibody (p) was raised against the
canine cardiac exchanger and has been described previously (Phil-
ipson et al., 1988). The secondary antibody was goat anti–rabbit
IgG coupled to horseradish peroxidase. Diaminobenzidine was
used as substrate for color development.
Indirect Immunofluorescent Labeling
Isolated mouse myocytes, either from control hearts or trans-
genic hearts, were fixed with 2% buffered formaldehyde for 15
min. The fixed cells were quenched in Na1 borohydrate, treated
with Triton X-100, and exposed to blocking solution and the
monoclonal antibody R3F1 (1/500 dilution) against the Na1-Ca21
exchanger, as previously described (Frank et al., 1992; Chen et
al., 1995). The cells were incubated with fluorescein-labeled goat
anti–mouse secondary antibody for 45 min, rinsed, and mounted
on glass slides with 90% glycerol plus a photobleaching inhibitor.
The confocal fluorescence microscopy was carried out with a Ni-
kon photomicroscope equipped with a molecular dynamic con-
focal imaging system.
Transport Measurements in Isolated Vesicles
A crude membrane fraction was prepared for measurement of
Na1-Ca21 exchange fluxes. Mouse hearts (z100 mg) were ho-
mogenized in 1.4 ml of 560 mM NaCl, 10 mM Mops/Tris, pH 7.4,
and spun in an Eppendorf centrifuge for 4 min at 11,000 rpm.
The pellet was resuspended in 0.9 ml of 140 mM NaCl, 10 mM
Mops/Tris, pH 7.4 and spun for 4 min at 11,000 rpm. The pellet
was resuspended in 0.8 ml of the same solution and spun briefly
(5 s) at 4,000 rpm to remove particulate material. The superna-
tant, containing Na1-loaded membrane vesicles was used directly
for Ca21 uptake measurements. The protein yield in the final
fraction was identical for the control and transgenic mice.
To measure Na1 gradient–dependent 45Ca21 uptake, 10 ml of
the supernatant was rapidly diluted into a Ca21 uptake medium
containing 140 mM KCl, 10 mM 45Ca21, 1 mM valinomycin, 10
mM Mops/Tris, pH 7.4. The reaction was quenched after 3 s and
then filtered. A blank was subtracted in which the uptake me-
dium contained NaCl instead of KCl. We have used this tech-
nique extensively in the past to quantitate vesicular Na1-Ca21 ex-
change (Li et al., 1991).
Isolation of Adult Mouse Ventricular Myocytes
Adult mouse ventricular myocytes were isolated according to a
previously described method (Mitra and Morad, 1985) with mi-
nor modification. After injection of heparin sodium (1,000 U/
kg, i.p.), mice were deeply anesthetized with sodium pentobar-
bital (50 mg/kg, i.p.), hearts were quickly excised and perfused
in a Langendorff apparatus (1.2–1.6 ml/min) first with nomi-
nally Ca21-free Tyrode’s solution composed of (in mM) NaCl,
137; KCl, 5.4; HEPES, 10; MgCl2, 1; glucose, 10; pH 7.3 at 378C
for 7 min, then with Ca21-free Tyrode’s solution containing colla-
1Abbreviations used in this paper: a-MHC, a-myosin heavy chain; SR, sar-
coplasmic reticulum.719 Adachi-Akahane et al.
genase (0.5–0.6 Us/ml) and protease (0.55 Us/ml) for 15 min, and
finally with low Na1 Tyrode’s solution. The ventricular part of the
digested heart was then cut into several sections and gently agi-
tated to dissociate cells. The freshly dissociated cells were stored
at room temperature in low Na1 Tyrode’s (in mM: 52.5 NaCl, 4.8
KCl, 1.19 KH2PO4, 1.2 Mg SO4, 11.1 glucose, 10 HEPES, 145 su-
crose, pH 7.4) containing 0.2 mM Ca21 and were used for up to
10 h after isolation. In all of the electrophysiological experiments,
the transgenic mouse line H was used.
Current Recording
Ca21 current was measured in the whole cell configuration of
the patch-clamp technique (Hamill et al., 1981) using a DAGAN
8900 amplifier (Dagan Corp., Minneapolis, MN). The patch elec-
trodes, made of borosilicate glass capillaries, were fire-polished to
have a resistance of 1.2 to 2.0 MV when filled with the internal
solution composed (in mM): CsCl, 110; tetraethylammonium
chloride (TEA-Cl), 30; NaCl, 10; HEPES, 10; MgATP, 5; cAMP,
0.2; K5Fura-2, 0.1–2.0 and titrated to pH 7.4 with CsOH. Inward
rectifier K1-current was suppressed by either addition of Ba21
(0.1 mM) to or omission of K1 from the external solutions. Na1-
current was mostly suppressed by addition of 10 mM tetrodotoxin
to the external solution, and by including a high concentration
(200 mM) of cAMP in the internal solution (Schubert et al., 1989).
Myocytes were dialyzed with 200 mM cAMP not only to enhance
ICa but also to fully activate Ca-ATPase activity through phosphor-
ylation of phospholamban.
Generation of voltage-clamp protocols and acquisition of data
were carried out using pCLAMP software (version 5.5-1; Axon In-
struments, Inc., Foster City, CA). The leak currents were not digi-
tally subtracted by the P/N method (N 5 5–6) as to avoid sup-
pression of maintained components of INa-Ca. Thus, we chose cells
which had little or no leak currents. The series resistance was 1.5
to 3 times the pipette resistance and was electronically compen-
sated through the amplifier. Sampling frequency was 0.5–2.0
kHz, and current signals were filtered at 10 kHz before digitiza-
tion and storage.
Intracellular Calcium Measurements
Intracellular calcium activity was measured according to the
method described earlier (Cleemann and Morad, 1991). Ventric-
ular myocytes were dialyzed with 0.1–2.0 mM Fura-2 via the patch
pipettes. Ultraviolet light originated from a 100 W mercury arc
lamp, was split into two beams using a mirror vibrating at 1,200
Hz, and passed through the interference filters (410 and 335 nm,
20 nm bandwidth). The fluorescent light passed through a wide-
band interference filter (510 nm, 70 nm bandwidth) and was de-
tected with a photo-multiplier. The signal from the photo-multi-
plier was demultiplexed (Cleemann and Morad, 1991), yielding
two signals corresponding to the two wavelengths of excitation.
These signals were acquired simultaneously with the whole-cell
currents using pCLAMP software. Cai -transients were quantified
using FURA 2N program (Adachi-Akahane et al., 1996).
The data collected with dual wavelength excitation of Fura-2
were analyzed to determine the intracellular Ca21 activity ([Ca21]i)
by the ratiometric method with a Kd value of Fura-2 for Ca21 as
220 nM (Grynkiewicz et al., 1985). The background fluorescences
(F410,bg and F335,bg) were measured after making a giga-seal
just before rupture of the membrane. Calibration measurements
were performed with samples of 50 mM Fura-2 either saturated
with 5 mM Ca21 (F410,Ca and F335,Ca) or in free form with 10 mM
EGTA (F410,EGTA and F335,EGTA).
Drugs were dissolved in the external Tyrode’s solution, and ap-
plied rapidly using a concentration-clamp device (Cleemann and
Morad, 1991).
All the experiments were performed at room temperature
(22–258C).
Collagenase (type A) was purchased from Boehringer-Mann-
heim Biochemicals (Indianapolis, IN), Protease (type XIV, pro-
nase E) and MgATP from Sigma Chemical Co. (St. Louis, MO),
thapsigargin and tetrodotoxin from Calbiochem Corp. (La Jolla,
CA), and K5Fura-2 salt from Molecular Probes, Inc. (Eugene,
OR). Thapsigargin was dissolved in DMSO and stored as 1023 M
stock solution. The highest (0.1%) concentration of DMSO used
had no effect by itself on ICa or Cai-transients.
results
Transgenic Mice, Their Molecular and
Ultrastructured Characterization
Transgenic mouse lines were produced to overexpress
the canine cardiac Na1-Ca21 exchanger in mouse myo-
cardium. The transgene used in these experiments (Fig.
1) contained the open reading frame of the canine sar-
colemmal Na1-Ca21 exchanger under the control of
the a-MHC promoter. This promoter has been used
previously in transgenic experiments for cardiac-specific
expression (Milano et al., 1994; Soonpaa et al., 1994;
Koch et al., 1995). Eight transgenic mouse lines, called
lines A through H, were generated. The transgenic
mice were all heterozygous so that in all cases nontrans-
genic littermates could be used for controls. The mice
had no readily observable altered phenotype; body and
heart weights were all normal. No differences between
the transgenic mouse lines were detected unless specifi-
cally mentioned below. Table I compares some electro-
physiological properties of the myocytes not directly re-
lated to the exchanger activity in control and trans-
genic mice. The size of the myocytes (cell capacitance),
the resting Ca21 concentrations (basal [Ca]i), the mag-
nitude of triggered Cai-transients (DCai), and the Ca21
current density (ICa) were not significantly altered in
transgenic mice.
Molecular Evidence for Overexpression of the
Na1-Ca21 Exchanger
Northern blot analysis. We first analyzed RNA from con-
trol and transgenic mouse hearts for levels of ex-
changer transcript derived from the transgene in the
Figure 1. Transgene construct. The open reading frame (ORF)
of the Na1-Ca21 exchanger was under the control of the a-MHC
promoter. For details, see text.720 Na1-Ca21 Exchange Overexpression
different transgenic mouse lines. The native mouse ex-
changer has a transcript size of 7 kb; most of the size of
the transcript is due to extensive 59- and 39-untrans-
lated regions with the open reading frame of the ex-
changer being only 3 kb. Most of the untranslated re-
gions have been removed in the construction of the
transgene and the expected size of the transcript in this
case is 3.2 kb. Thus, it is straightforward to distinguish
the two transcripts by Northern blot analysis.
Fig. 2 A shows a Northern blot with RNAs isolated
from the hearts of transgenic mice and their nontrans-
genic littermates from six different lines probed with
an exchanger cDNA probe. A strong signal from RNA
isolated from the transgenic hearts is seen at 3 kb after
an exposure of only 1 h. With such short exposure
times, no signal is observed with the RNA from the con-
trol mice. A signal from the native exchanger becomes
visible at 7 kb in all lanes after longer exposures (not
shown, but see Fig. 2 B). Similar results were obtained
for transgenic mouse lines B and E. Clearly, substantial
amounts of RNA are being transcribed from the trans-
gene.
The a-MHC promoter is supposed to permit gene ex-
pression only in cardiac tissue, therefore we next as-
sessed the tissue specificity of exchanger transgene ex-
pression. Fig. 2 B shows the results of a Northern blot
analysis using RNA isolated from the heart, lung, brain,
or skeletal muscle of transgenic mice or nontransgenic
littermates from line H. In this case, a longer exposure
time was used to permit visualization of both the native
and transgenic Na1-Ca21 exchangers. In the tissues from
the nontransgenic mice, a weak signal at 7 kb from the
native exchanger is seen only in the RNA from the car-
diac tissue. (Upon longer exposure, 7-kb bands also be-
come visible in the RNA from brain and lung.) In the
RNAs from the transgenic mice, a strong signal is seen
only with the cardiac RNA at 3 kb (transgenic ex-
changer) and a weak signal is seen at 7 kb (native ex-
changer). Not visible in the photograph, but discern-
ible by eye, is a low level of expression of the 3-kb trans-
genic exchanger in the lung of transgenic mice. This was
also seen in lung RNA from other transgenic mouse
lines. Thus, the a-MHC promoter was not completely
silent in lung tissue. In one transgenic mouse line (line
E), expression of transgene transcripts were much higher
in lung than in the other transgenic lines though still
many fold lower than the expression level in heart.
Line E was also the only line in which transgene tran-
scripts could also be weakly detected in brain RNA.
Subramaniam et al. (1991) have previously noted a low
level of a-MHC gene expression in lung tissue, specifi-
cally in the thick wall of the pulmonary veins of the
lung. Nevertheless, of those tissues tested, high levels of
transgenic Na1-Ca21 exchanger transcript were found
only in the myocardium.
Western blot analysis. Immunoblots were performed to
assess the level of Na1-Ca21 exchanger protein in the
hearts of the transgenic mice. The proteins of myocar-
dial homogenate were separated by SDS-PAGE and
probed with a polyclonal antibody to the canine sar-
colemmal Na1-Ca21 exchanger. Strong immunoreactiv-
ity is seen in the transgenic hearts but not in the hearts
table i
Ca21 Current (ICa) and Ca21
i-transient (D[Ca21]i Triggered by ICa in Nontransgenic (Control) and Transgenic Myocytes
ICa(pA) Capacitance (pF) ICa Density (pA/pF) Basal [Ca21]i (nM) D[Ca21]i (nM)
control 2,189 6 207 192 6 9 11.6 6 1.1 126 6 13 364 6 22
(19) (19) (14) (10) (10)
transgenic 2,129 6 209 204 6 7 10.5 6 0.9 142 6 21 337 6 23
(31) (31) (16) (15) (15)
ICa were activated by giving depolarizing pulses from 260 to 210 mV. Data are represented as the mean 6 SEM (number of experiments).
Figure 2. Na1-Ca21 exchanger transcript expression in trans-
genic mice (A) RNA was isolated from the hearts of transgenic (T)
mice or nontransgenic (N) littermates from transgenic mouse
lines A, C, D, F, H, and G, as indicated. After hybridization, the
Northern blot was exposed to film for 1 h. (B) Northern blot anal-
ysis was performed using RNA isolated from the heart (H), lung
(L), brain (B), and skeletal muscle (S) of transgenic mice (T) or
nontransgenic littermates (N) from line H. After hybridization
with an NCX1 cDNA probe, the Northern blot was exposed to film
for 6 h. 10 mg of total RNA was run in each lane.721 Adachi-Akahane et al.
from control littermates (Fig. 3). The protein bands
which immunoreact have a similar pattern to that seen
with isolated canine sarcolemmal membranes, a posi-
tive control (Philipson et al., 1988). The transgenic ex-
changer protein bands, however, appear to be of slightly
smaller molecular weight than those of the isolated sar-
colemma, perhaps due to a small difference in amount
of glycosylation. We have previously demonstrated that
glycosylation does not affect exchanger function (Hry-
shko et al., 1993).
The native mouse exchanger of the control mouse
hearts produces only a weak immunoreactivity under
these conditions, though at the same apparent molecular
weight as the transgenic exchanger protein. The strength
of the immunoreactivity, however, cannot be used to esti-
mate quantitatively the amount of exchanger overex-
pression. The antibody was produced using the canine
heart exchanger as antigen and thus may react more
weakly with the native mouse heart exchanger than with
the canine exchanger encoded by the transgene. Quali-
tatively, however, the Western blot clearly demonstrates
that a substantial amount of Na1-Ca21 exchanger pro-
tein is being translated from transgene transcripts.
Immunofluorescence
Overexpression of the Na1-Ca21 exchanger is also clearly
demonstrated by immunofluorescence (Fig. 4). The
confocal micrographs of the control (Fig. 4 A) and
transgenic (Fig. 4 B) myocytes were taken under identi-
cal conditions. In the transgenic myocytes, there is in-
tense labeling of both the surface and t-tubular sarco-
lemma as well as the area surrounding the nucleus
which is presumably the Golgi apparatus involved in
protein trafficking. As described above, the antibody
reactions cannot be used for quantitative comparison
of exchanger expression.
We had previously found a preferential localization
of the Na1-Ca21 exchanger in that part of the sarco-
lemma which forms the t-tubules in guinea pig and rat
myocytes (Frank et al., 1992). This preferential localiza-
tion is much less obvious in mouse myocytes in which
strong staining of the peripheral sarcolemma is also ob-
served. This species difference may be related to the
large amount of peripheral sarcoplasmic reticulum found
in mouse myocytes (J.S. Frank, unpublished observa-
tions). Thus, even the Na1-Ca21 exchangers found in
surface sarcolemma in mouse myocytes may be in close
proximity to underlying sarcoplasmic reticulum.
Evidence for functional overexpression of the Na1-Ca21 ex-
changer. Two types of experimental protocols using
freshly isolated ventricular myocytes and one set of ex-
periments using a crude membrane preparation were
employed to examine the exchanger activity in control
and transgenic mice.
In the first set of experiments we prepared a crude
myocardial membrane fraction and assayed for Na1
gradient-dependent 45Ca21 uptake. In a second set of
experiments, Fura-2-dialyzed myocytes were clamped at
holding potentials of 290 mV and were subjected to
rapid (,50 ms) application of 5 mM caffeine to induce
Ca21 release from the SR to activate a transient Ni21-
Figure 3.  Immunoreactiv-
ity of Na1-Ca21 exchanger
protein in transgenic mouse
hearts. Shown is Western
blot reacted with a poly-
clonal antibody to the canine
cardiac Na1-Ca21 exchanger.
Loaded in each lane was ca-
nine cardiac sarcolemmal
membranes (10 mg) as a
positive control or 50 mg of
cardiac homogenate protein from transgenic (T) mice or non-
transgenic (N) littermates from mouse lines D and A. Antibody di-
lution was 1/1,000.
Figure 4. Confocal microscope images of isolated mouse myo-
cytes immunolabeled with monoclonal antibodies (R3F1) against
the Na1-Ca21 exchange protein. Both cells were incubated under
the same conditions. The gain of the confocal microscope was set
to the lowest level to allow the control cell (top) to be just visible.
Under these conditions the transgenic myocytes (bottom) have in-
tense labeling of the surface sarcolemma and t-tubules indicating
considerable expression of Na1-Ca21 exchanger protein in the
membrane. Also intensely labeled is the area surrounding the nu-
clei which presumably represents the Golgi. Magnification, 6603.722 Na1-Ca21 Exchange Overexpression
sensitive inward INa-Ca (Ca21-extrusion mode of the ex-
changer; Callewaert, Cleemann and Morad, 1989). In a
third set, long (1–2 s) depolarizing pulses to positive
potentials were used to measure the Ca21 influx mode
of the exchanger. The maintained outward Ni21-sensi-
tive current and the accompanying rise in [Ca21]i were
quantified to represent Ca21 transported by the ex-
changer (Kimura et al., 1986; Näbauer and Morad, 1992).
Na1-Ca21 exchange activity in cardiac membrane fraction.
We prepared crude membrane fractions and assayed
Na1 gradient-dependent  45Ca21 uptake. Results obtained
using hearts from transgenic mouse line H are shown
in Fig. 5. Na1-Ca21 exchange activity is 148% higher in
vesicles from transgenic hearts than in vesicles from the
hearts of control littermates. The level of overexpres-
sion in vesicles from transgenic hearts from other mouse
lines averaged about 100%, though due to scatter, it
was not clear if there were significant differences. The
level of overexpression as assessed electrophysiologically
from line H mice (see Table II) appears to be somewhat
larger than that measured in vitro by isotope flux.
Activation of exchanger by caffeine and Ca21 channel-induced
Ca21 release. Fig. 6 compares the Ca21 transients trig-
gered by rapid (,50 ms) application of caffeine in two
isolated whole-cell clamped ventricular myocytes dia-
lyzed with 0.2 mM Fura-2. In control mice, 5 mM caf-
feine triggered a Cai-transient and a slowly activating
exchanger current of about 250 pA decaying with a
time constant of 300 ms. In transgenic myocytes, al-
though the caffeine-triggered Cai-transient was similar
in magnitude, the accompanying exchanger current
was three times larger than in control mice. In addi-
tion, the kinetics of decay of both the exchanger cur-
rent and Cai-transients in transgenic myocytes were two
to threefold faster than those of control myocytes. In
control as well as transgenic myocytes, 5 mM Ni21 effec-
tively blocked the caffeine-induced INa-Ca but allowed
the Cai-transient to develop. Fig. 6 (transgenic 1 Ni21)
shows that the strong suppression of INa-Ca by Ni21 in
transgenic mice is accompanied by a 20-fold reduction
in the rate of decay of Ca21 transients, confirming the
prominent role of the exchanger in the Ca21 efflux pro-
Figure 6. Caffeine-induced Cai-
transients and INa-Ca in control
and transgenic myocytes. Na1-
Ca21 exchange current was acti-
vated by Ca21-release from the
SR triggered by rapid application
of 5 mM caffeine at a holding po-
tential of 290 mV. INa-Ca ( top)
and Ca21
i-transient (bottom) re-
corded from a control myocyte.
The timing of caffeine applica-
tion is indicated by the shaded
bar. Similar recordings from a
transgenic myocyte in the ab-
sence and presence of 5 mM
NiCl2 as indicated. Cell capaci-
tance of control and transgenic
myocytes were 257.9 pF and
239.7 pF, respectively. Fura-2
concentration was 0.2 mM. Data
was obtained at room tempera-
ture (z258C).
Figure 5. Na1-Ca21 exchange activity in isolated membranes.
45Ca21 uptake into Na1-loaded membrane vesicles was determined
in the presence (K1) or absence (Na1) of an outwardly directed
Na1 gradient. The external uptake media in these cases contained
KCl or NaCl, respectively. The difference in 45Ca21 uptake from
the K1 or Na1 media is taken as Na1-Ca21exchange activity. Vesi-
cles were prepared from the hearts of transgenic (T) or nontrans-
genic littermates (N). Media contained 10 mM Ca21 and the uptake
period was 3 s. n 5 3 and error bars represent the S.D.723 Adachi-Akahane et al.
cess. Comparison of the rates of decay of Cai-transients
and INa-Ca suggests a two to threefold increase in the ki-
netics of Ca21 extrusion in transgenic myocytes (Table
II). In 14 control and 16 transgenic myocytes dialyzed
with 100–200 mM Fura-2, the Ni21-sensitive current (INa-Ca)
averaged about 1.6 and 5.0 pA/pF, respectively (see Table
II). Though the magnitude of Ca21 release was not signifi-
cantly different in control and transgenic myocytes, the
exchanger activity was enhanced in transgenic myocytes
by all three criteria tested: the magnitude of INa-Ca, the ki-
netics of INa-Ca, and the rate of decay of Cai-transients.
Table II quantifies some of the parameters of INa-Ca
and the accompanying Cai-transients in transgenic and
control myocytes. The size of the caffeine-triggered Ca21
pool was found to be equivalent in control and trans-
genic myocytes. Comparison of the caffeine-releasable
pool in normal and transgenic mice in the presence of
5 mM Ni21 revealed a somewhat larger caffeine-sensi-
tive pool in transgenic. In addition, the rate of release
of Ca21 (an indirect indication of flux of Ca21 through
the ryanodine receptor), though equivalent in control
and transgenic mice, was enhanced in the presence of
Ni21 only in transgenic myocytes (Table II). These find-
ings suggest that the higher exchanger activity reduces
the cytosolic Ca21 concentrations very rapidly in trans-
genic mice. It is premature to suggest possible compen-
satory Ca21 adaptive pathways, as we do not have direct
data on the activity or regulation of SR and SL Ca21
pumps, the ryanodine receptors, and, in particular,
Ca21 storing proteins such as calsequestrin in myocytes
overexpressing the exchanger. Some indication as to
the activity of SR Ca21 pump in transgenic myocytes was
obtained by comparing the rate of relaxation of Cai-
transient, triggered by brief (50 ms) pulses of caffeine,
in Na1-free solutions. Yao and Barry (personal commu-
nication) found no significant differences in the rate of
relaxation of Ca21-transients between control and
transgenic myocytes. Although such studies are compli-
cated by the rate of dissociation of Ca21 from the dye,
they nevertheless do not support compensatory enhance-
ment of Ca21 ATPase activity in transgenic myocytes.
Compensatory responses in transgenic mice showing
no phenotypic changes, as was the case here, are likely
to be subtle and multifaceted. Upregulation of calse-
questrin, for example, could serve as a possible mecha-
nism by which the SR could maintain its Ca21 load in
the face of overexpression of exchanger protein. Such
an idea is supported by a recent study that reports
upregulation of Ca21 release pools in transgenic mice
overexpressing cardiac calsequestrin (Suzuki et al., 1997).
Fig. 7 illustrates ICa-gated Ca21 release in two myo-
cytes obtained from transgenic and non-transgenic lit-
termates. In both cell types the magnitude of ICa and
Cai-transients were similar (see also Table I). In trans-
genic cells, however, ICa measured between 220 and 120
mV was consistently followed by a slowly activating “tran-
sient inward current” during the rise of [Ca21]i. Fur-
ther, a slowly decaying tail current was observed on repo-
larization of the membrane. Both the “transient inward
current” and the slowly decaying tail currents were abol-
ished by depletion of SR Ca21 stores by incubation of
myocytes in thapsigargin or caffeine (data not shown). A
similar (intracellular Ca21 store-dependent) transient in-
ward current and large slowly inactivating inward tail
currents, abolished by replacement of extracellular Na1
with Li1, were also reported in myopathic hamster myo-
cytes overexpressing the exchanger (Hatem et al., 1994).
Measurement of Exchanger Current in the Ca21 Influx Mode
Normal and transgenic myocytes dialyzed with 10 mM
Na1 were depolarized to 160 or 180 mV to minimize
table ii
Caffeine-induced Na-Ca Exchange Current and Cai-transient at Holding Potential of 290 mV in Ventricular Myocytes from 
Nontransgenic (Control) and Transgenic Mice
INa-Ca Density
(pA/pF)
tINa-Ca-decay
(ms)
D[Ca21]i
(nM)
tCai-decay
(ms)
[Ca21]i/dt
(mM/s)
Capacitance
(pF)
control 1.61 6 0.16
(14)
304 6 23
(9)
410 6 26
(14)
1,186 6 282
(12)
4.8 6 0.4
(14)
206 6 11
(14)
transgenic 4.96 6 0.63*
(16)
126 6 13*
(10)
437 6 31
(16)
486 6 54*
(16)
5.1 6 0.4
(16)
213 6 9.0
(16)
control 1.32 6 0.22
(3)
388 6 19
(3)
764 6 131
(3)
5.1 6 0.6
(3)
1.88 6 19
(3)
control 1 Ni21 0.08 6 0.08
(3)
458 6 13‡
(3)
3,511 6 1659
(3)
4.2 6 0.3
(3)
transgenic 5.52 6 2.07
(4)
422 6 48
(4)
457 6 113
(4)
6.2 6 1.1
(4)
206 6 8
(4)
transgenic 1 Ni21 0.13 6 0.07
(4)
698 6 125§
(4)
6,278 6 1375§
(4)
8.3 6 1.2§i
(4)
Data are represented as the mean 6 SEM (number of experiments). *Significantly different from control at P , 0.05. ‡Significantly different from con-
trol at P , 0.05. §Significantly different from transgenic at P , 0.05. iSignificantly different from control 1 Ni21 at P , 0.05.724 Na1-Ca21 Exchange Overexpression
the influx of Ca21 through the Ca21 channel and en-
hance Ca21 influx via the exchanger.
In myocytes from control mice (Fig. 8 A) a small
Ni21-sensitive INa-Ca consistently accompanied a small
rise in [Ca21]i in thapsigargin-treated myocytes (Fig. 8
B). Even though the rise in myoplasmic [Ca21] induced
by the exchanger was small in control myocytes (Fig. 8
A), repolarizing to 280 mV activated ICa “tails” trigger-
ing significant release of Ca21. In thapsigargin-treated
myocytes, the rise in [Ca21]i in response to depolariza-
tion was somewhat larger than in control myocytes (Fig.
8 B), but Ca21 release triggered by Ca21 channel tail
current was absent (compare Fig. 8 A with B). These re-
sults suggest that the small rise of [Ca21]i induced by
the influx of Ca21 via the exchanger in control mice is
blunted by the SR activity. In transgenic myocytes, how-
ever, depolarizing pulses to less positive voltages (160
mV, Fig. 8, C and D) produced much larger rises in
[Ca21]i, often triggering Ca21 release from the SR (Fig.
8 C) which activated a transient current in the inward
direction at 160 mV, representing Ca21 extrusion by
the exchanger (Fig. 8 C). 6–8 min exposure of transgenic
myocytes to 1.0 mM thapsigargin completely suppressed
Figure 7. ICa-induced Ca21 release ac-
tivated “transient inward current” in
transgenic but not in control myocytes.
Whole cell ICa and Cai-transient were si-
multaneously recorded from nontrans-
genic (control, A) and transgenic (B)
myocytes. Myocytes were dialyzed with
0.1 mM Fura-2 through patch pipette.
ICa were activated by giving depolarizing
pulses to 210 mV from a holding po-
tential of 260 mV every 10 s. Cell ca-
pacitance in A was 151 pF and in B was
235 pF.
Figure 8. Cai-transients and INa-Ca currents in control and trans-
genic myocytes in the presence and absence of thapsigargin. The
activity of Na1-Ca21 exchanger activity in the Ca21 influx mode was
measured by applying depolarizing pulses to positive potentials
near ECa. (A) Superimposed current traces (top) and the simulta-
neously measured [Ca21]i (bottom) during the application of a de-
polarizing pulse to 180 mV in control myocyte in the presence
and absence of 5 mM NiCl2. (B) Similar recordings obtained from
the myocyte shown in A after treatment of myocyte with 1.0 mM
thapsigargin. (C) Cai-transients and ICa measured at 160 mV in a
transgenic myocyte overexpressing Na-Ca exchanger. (D) The su-
perimposed recordings from the same transgenic myocyte as
shown in C after treatment with 1.0 mM thapsigargin in the pres-
ence and absence of 5 mM NiCl2. Cell capacitance was 151 pF (A
and B) and 228 pF (C and D). Myocytes were dialyzed with 0.2 mM
Fura-2 concentration.725 Adachi-Akahane et al.
Ca21 release and the inwardly directed transient cur-
rent deflections (Fig. 8 D). Instead, intracellular Ca21
slowly but continuously increased to values of 500–600
nM during the depolarizing pulses. 5 mM Ni21 blocked
INa-Ca, completely suppressed the rise in intracellular
Ca21, and abolished the slowly decaying exchanger-
generated tail currents following the repolarization
(Fig. 8 D).
Thus, in sharp contrast to myocytes from control
mice, the transgenic myocytes produce large and rapid
rises in myoplasmic Ca21 in response to activation of
the Na1-Ca21 exchanger. In 9 of 26 transgenic myo-
cytes, the influx of Ca21 via the Na1-Ca21 exchanger
caused rapid rise in myoplasmic Ca21 (SR Ca21 release)
at 160 to 180 mV, the rate of which was strongly sup-
pressed by caffeine. In 11 myocytes significant rise of
[Ca21]i was observed by depolarization without trigger-
ing Ca21 release. In the remaining 6 myocytes, the large
depolarizations failed to cause significant rise of [Ca21]i
even though large caffeine-induced INa-Ca was recorded.
In contrast to transgenic myocytes, in only 5 of 15 con-
trol myocytes, significant rise of [Ca21]i was observed
upon application of large and long depolarizations. In
the other 10 myocytes no significant change of [Ca21]i
could be observed at all, and in none of the 15 cells could
we trigger Ca21 release from the SR even at 180 mV.
Fig. 9 shows that Ca21 influx via the exchanger is sig-
nificantly blunted by a functional SR even in transgenic
mice. In this myocyte, depolarization from 280 to 80
mV caused only slight increase in [Ca21]i, although re-
polarization from 80 to 280 mV triggered Ca21 release
via Ca21-influx through the deactivating L-type Ca21
channels. Ni21 at 5 mM concentration blocked both
Ca21 influx transported via the exchanger and the Ca21
channels. The same myocyte, treated with 5 mM caf-
feine however, showed significant rise in [Ca21]i during
the pulse to 180 mV (Fig. 9 B). This large rise of [Ca21]i
was completely suppressed by 5 mM Ni21.
Relative Contributions of the Na1-Ca21 Exchanger and Ca21 
Channel in Signaling of Ca21 Release in Transgenic Mice
Fig. 10 examines the ability of the exchanger and Ca21
channel to detect local rises in [Ca21]i in transgenic
myocytes dialyzed with 2 mM Fura 2 (high concentra-
tions of Ca21 buffer were used to prevent significant
rise in global cytoplasmic Ca21 concentrations; Adachi-
Akahane et al., 1996; Sham et al., 1995a). The experi-
ment was designed to induce Ca21 release first by caf-
feine and then by ICa. Thus it was possible to measure
almost simultaneously the magnitude of INa-Ca activated
by caffeine, or ICa activated by depolarization, and their
respective Cai-transients. Although 2 mM Fura-2 com-
pletely suppressed the activation of caffeine-induced
INa-Ca, it did not suppress cross signaling between DHP
and ryanodine receptors (Fig. 10 B). Fig. 10 B also
shows that ICa, activated following the depletion of Ca21
pools by caffeine, was somewhat larger, triggered a
small Cai-transient, and inactivated significantly more
slowly (Fig. 10 C). These results were similar to those
observed in control mice myocytes and suggest that
even though the density of the exchanger current is
strongly enhanced in transgenic mice, the exchanger
remains more susceptible to cytoplasmic Ca21-buffer-
ing than the Ca21 channel. Thus, in the presence of 2
mM Fura-2, the Ca21 channel continues to signal Ca21
Figure 9. Enhancement of Ca21 in-
flux by Na1-Ca21 exchanger after im-
pairing the Ca21 storage capacity of the
SR by caffeine. (A) Exchanger-depen-
dent currents and rise in [Ca21]i in
transgenic myocyte were elicited by de-
polarization from 280 to 80 mV. In this
myocyte, large depolarization did not
cause significant rise in [Ca21]i, al-
though repolarization from 80 to 280
mV triggered ICa-dependent Ca21 re-
lease, which, in turn, activated INa-Ca in-
ward current. (B) Membrane currents
and changes in [Ca21]i recorded for the
same transgenic myocyte (shown in A)
in the presence of 5 mM caffeine. The
intracellular rise in Ca21 with depolar-
ization was significantly higher in the
presence of caffeine and repolarization
no longer triggered Ca21-release be-
cause SR Ca21 pools were depleted in
presence of caffeine. Cell capacitance
in A and B was 214 pF. Fura-2 concen-
tration in the patch pipette was 0.2 mM.726 Na1-Ca21 Exchange Overexpression
release (Fig. 10 A), and is in turn regulated by Ca21 re-
leased via the ryanodine receptors (Fig. 10 C). We con-
clude that increasing the density of INa-Ca by at least
threefold does not give the exchanger the type of ac-
cess to the ryanodine receptor as that of the Ca21 channel.
Fig. 11 illustrates an experimental protocol to deter-
mine the fractional contribution of the Ca21 channel
and the exchanger in signaling Ca21 release from the
SR in transgenic myocytes dialyzed with low concentra-
tions of Ca21 buffer (0.1 mM Fura 2). Transgenic myo-
cytes were voltage clamped at 10-s intervals, from 260
to 210 mV and from 260 to 150 mV in control solu-
tions and following 10–20-s application of 0.1 mM
Cd21. Fig. 11 A shows that in control solution activation
of Ca21 currents triggers Ca21 release in transgenic my-
ocytes and that rapid application of Cd21 blocks ICa and
the rise in [Ca21]i (traces marked with *). In panel B,
the cell is clamped to 150 mV activating an outward
current accompanied by a small rise in [Ca21]i. Upon
repolarization, a slowly decaying inward INa-Ca is mea-
sured following the triggering of Ca21 release by the
Ca21 channel tail current. The traces marked (by *)
were obtained in the presence of 0.1 mM Cd21 and
show that Cd21 blocked the Ca21 channel tail current,
the rapid rise in [Ca21]i, and the accompanying INa-Ca.
This is similar to findings in normal mice myocytes (not
shown) and reported previously in rat heart (Sham et
al., 1992). Thus it appears that the Ca21 channel, even
in myocytes overexpressing the exchanger, remains the
primary pathway for gating the ryanodine receptor.
discussion
The main finding of this report is that we have suc-
ceeded in producing transgenic mice that overexpress
the canine sarcolemmal Na1-Ca21 exchanger (NCX1)
Figure 10. Dialysis of transgenic myo-
cytes with high concentrations of Ca21
buffer does not block cross signaling be-
tween Ca21 channel and ryanodine re-
ceptor but blocks activation of ex-
changer with caffeine-induced Ca21 re-
lease. Ca21 release by caffeine (5 mM)
did not activate inward Na1-Ca21 ex-
change current at 290 mV (middle, in a
cell dialyzed with 2 mM Fura-2) but al-
tered the rate of inactivation of ICa in
panel A (normalized Ca21 current trac-
ings before and after 600-ms exposure
to caffeine are compared in panel C).
Depletion of SR Ca21 pools by caffeine
slowed the inactivation kinetics of ICa
even though the rise in [Ca21]i failed to
activate INa-Ca. Cell capacitance was
178.1 pF.
Figure 11. Cd21 blocks Ca21 release
by blocking ICa at 210 and 150 mV in
transgenic myocytes. Membrane cur-
rents and Cai-transients activated by de-
polarizing pulses in transgenic myocytes
dialyzed with 0.2 mM Fura-2 were re-
corded at 10-s intervals before and fol-
lowing addition of 0.1 mM Cd21(*). ICa,
tail current, and Ca21
i transient acti-
vated by test pulses from 260 to 210
mV (A) or to 50 mV (B) were abolished
within a few 100 ms by 100 mM Cd21.
Cd21 increased the net membrane in
the outward direction (*) at 150 mV
and blocked the Ca21 transient. The
current traces were not leak-subtracted,
so as not to suppress the approximately
linear components of INa-Ca. Cell capaci-
tance was 228 pF. Fura-2 concentration
in dialyzing patch pipette was 0.2 mM.727 Adachi-Akahane et al.
specifically in heart tissue. The report provides both
biochemical and functional evidence for overexpres-
sion in ventricular myocytes. The Na-Ca exchange cur-
rent density in transgenic mice myocytes was three times
higher, on the average, compared to that measured in
control myocytes (Table II). Overexpression of the ex-
changer did not significantly alter the Ca21 content of
Ca21-release pools or enhance the contribution of Na1-
Ca21 exchanger to the Ca21 release process. Overexpres-
sion of the exchanger did, however, accelerate the rate
of removal of Ca21 from the cytosol, when SR uptake
was impaired by caffeine. Even though overexpression
of the exchanger failed to trigger Ca21 release at physi-
ological membrane potentials, the exchanger did ap-
pear to blunt the rate of Ca21 release gated by ICa in
transgenic myocytes.
Consequences of Overexpression of the Exchanger
Since the exchanger is a major pathway for Ca21 extru-
sion from the cytosol, it may be expected that its over-
expression would reduce the Ca21 content of the SR.
Table II clearly shows that there was no significant de-
crease in Ca21 content of SR as assessed from the mag-
nitude of caffeine-induced Ca21 release (D[Cai], col-
umn 3). Such a finding is consistent with the absence
of significant changes in cardiovascular phenotypic pa-
rameters (e.g., heart rate and blood pressure) in trans-
genic mice overexpressing exchange activity (H. Rock-
man, personal communication). Table I, also, shows that
there were no significant differences in the density of
Ca21 channel current in control vs. the transgenic myo-
cytes. This finding supports the observation of a recent
report (Silverman et al., 1995) that the duration of the
action potential in these transgenic myocytes does not
change significantly at 50% duration, a period where
ICa may be the predominant inward current. Prolonga-
tion of the action potential measured at 90% of its du-
ration reported in the same study may have been caused
by the larger inward exchanger current (see Fig. 7).
Overexpression of the Exchanger and Ca21 Microdomains of 
DHP/Ryanodine Receptors
Recent data using high concentrations of Ca21 buffers
suggests that Ca21 signaling in cardiac muscle occurs
via microdomains of Ca21 (Sham et al., 1995a; Adachi-
Akahane et al., 1996). Fig. 10 shows that the release of
Ca21 by rapid application of caffeine in transgenic myo-
cytes failed to activate the inward exchanger current in
the presence of 2 mM Fura-2 (e.g. Fig. 6), even though
the kinetics of inactivation of ICa were markedly altered
after the release of Ca21 from the SR. One possible in-
terpretation is that the release of Ca21 from the ryano-
dine receptor is effectively buffered by 2 mM Fura-2,
placing the exchanger at microdomains outside of those
surrounding DHP and the ryanodine receptor. The dif-
ferential sensitivity of the exchanger for Ca21 transport
and the Ca21 channel to Ca21-induced inactivation,
however, may also contribute to the data of Fig. 10. The
sensitivity of Ca21 sites on the two proteins, however,
suggests about 5 mM affinity for the Ca21 transport site
of the exchanger (Matsuoka and Hilgemann, 1992) vs.
much higher Ca21 for Ca21 channel inactivation (10–15
mM Haack and Rosenberg, 1994; and 50–100 mM Mo-
rad et al., 1988). Thus the failure to activate INa-Ca while
strongly modulating the kinetics of inactivation of Ca21
channel is more consistent with the idea that the ex-
changer remains excluded from the Ca21 microdomains
surrounding the DHP/ryanodine receptor complex,
even in the transgenic mice.
Physiological Role of the Exchanger in Transgenic Myocytes
One reason for developing these transgenic mice was
to enhance the exchanger activity in the Ca21-influx
mode. The activity of the exchanger was enhanced in
most myocytes to levels where the density of current
carried by the exchanger in the Ca21 efflux mode was
about 5 pA/pF, compared to 1.6 pA/pF in control myo-
cytes (see Table II). Assuming that a similar increase in
the activity of the exchanger takes place at positive po-
tentials (Ca21 influx mode of the exchanger), densities
of current equivalent to those of Ca21 current may be
generated by the exchanger.
Ca21 influx via the exchanger when activated by large
and long depolarizing pulses did trigger Ca21 release in
9 out of 26 transgenic myocytes. However, z100–300
ms were required for the exchanger to activate the
Ca21-induced Ca21 release mechanism (Fig. 8). In part,
because of relatively low capacity of the exchanger ver-
sus that of the SR Ca21 pump (which may prevent sig-
nificant accumulation of cytosolic Ca21), the exchanger
fails to trigger Ca21 release on beat-to-beat basis, espe-
cially at high mouse heart rates (z6 Hz). In the physio-
logical range of membrane potentials, 210 to 120 mV,
we consistently failed to produce sufficient influx of
Ca21 via the exchanger to trigger Ca21 release in trans-
genic myocytes dialyzed with 0.1 mM Fura 2 (Fig. 11),
even though Ca21 release triggered by Ca21 current in-
duced a large inward exchanger current (Fig. 7). Even
though the exchanger may not have direct access to
Ca21 microdomains of the DHP/ryanodine receptor
complex even when overexpressed, the finding that
Ca21 release in transgenic myocytes was significantly en-
hanced when the exchanger was blocked by Ni21 (Ta-
ble II), places the exchanger within distances close
enough to the ryanodine receptor to blunt the Ca21-
induced Ca21-release process. Thus, the overexpressed
exchanger appears to produce functional consequences
in the Ca21 efflux, but not in the Ca21 influx mode.728 Na1-Ca21 Exchange Overexpression
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